Symbol="NEXI"
AssetType="Common Stock"
Name="Neximmune Inc"
Description="NexImmune, Inc., a clinical-stage biotechnology company, is dedicated to developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company is headquartered in Gaithersburg, Maryland."
CIK="1538210"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="9119 GAITHER ROAD, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="7654000"
EBITDA="-56823176"
PERatio="None"
PEGRatio="None"
BookValue="0.904"
DividendPerShare="0"
DividendYield="0"
EPS="-2.37"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.664"
ReturnOnEquityTTM="-1.214"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.19"
EVToRevenue="-"
EVToEBITDA="0.592"
Beta="2.19"
num_52WeekHigh="1.59"
num_52WeekLow="0.195"
num_50DayMovingAverage="0.311"
num_200DayMovingAverage="0.41"
SharesOutstanding="26078500"
DividendDate="None"
ExDividendDate="None"
symbol="NEXI"
open="0.29"
high="0.30"
low="0.28"
price="0.29"
volume="24060.00"
latest_trading_day="2023-07-25"
previous_close="0.30"
change="-0.00"
change_percent="-1.5101%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="240188"
Change_recent_avg="-0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-2.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="1113"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0146.jpeg"
image_negative_thumbnail_id_2="158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="541"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_positive_thumbnail_id_1="982"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_positive_thumbnail_id_2="688"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
